SPOTLIGHT -
Although the clinical symptoms of psychotic disorders are dramatic and are what most clinicians focus on as their treatment targets, impairments in a wide range of cognitive function are observed in these illnesses.
Postpartum Depression and Psychosis in Psychiatric Times
Treating ‘Morally Objectionable’ Patients
Phase 3 SOLARIS Trial Demonstrates Potential of TEV-‘749 in Schizophrenia
What Will the Future of Alzheimer Disease Treatment Look Like?
Investigators Share Baseline Data From Study on Iclepertin for Schizophrenia at APA Annual Meeting
Cognitive Impairment and Upcoming Agents for Long-Acting Schizophrenia Treatment